Rusan Pharma secures Japan PMDA GMP approval for API, FDF facilities
PMDA is regarded among the most stringent regulatory bodies globally
PMDA is regarded among the most stringent regulatory bodies globally
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
Move strengthens footprint in Western India and expands multi-specialty care network
Focus on preventive, tech-driven healthcare and digital ecosystem reforms under AB PM-JAY and ABDM
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Subscribe To Our Newsletter & Stay Updated